Epigenetic down‐regulation of MMR genes has also been linked with resistance to alkylating chemotherapy agents in CRC tumor models (Planck et al., 2003), and studies have demonstrated that preventing down‐regulation of MMR genes can restore cellular sensitivity to these agents (Francia et al., 2005). Here, MRC1 is linked to colorectal carcinoma.